Biotechnology / Medical Research
Coronado Biosciences Inc Announces Closing Of $28.8 Million Public Offering
Coronado Biosciences Inc announced that it closed its previously announced underwritten public offering of 5,750,000 shares of its common stock at a price to the public of $5.00 per share for gross proceeds to Coronado of $28.8 million. The shares include 750,000 shares of common stock sold pursuant...
Gilead Sciences, Inc. Submits New Drug Application To U.S. FDA For HIV Integrase Inhibitor Elvitegravir For Treatment Experienced Patients
Gilead Sciences, Inc. announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for marketing approval of elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced adults. Elvitegravir is also a component of...
Aastrom Biosciences, Inc. Announces Common Stock Exchange For December 2010 Warrants
Aastrom Biosciences, Inc. announced that it plans to exchange for common stock up to 10,000,000 of its outstanding warrants issued in December 2010. The warrants have an exercise price of $3.22 and an expiration date of December 15, 2015. Aastrom is exchanging one share of common stock for every two...
Arena Pharmaceuticals, Inc. And Eisai Announce FDA Approval Of BELVIQ for Chronic Weight Management In Adults who are Overweight With Comorbidity Or Obese
Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the U.S. Food and Drug Administration (FDA) has approved BELVIQ (pronounced BEL-VEEK) as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index...
Restructuring & Reorganization
Markets
- Sectors
- U.S.
- Europe
- Asia
Sector Summary
| Energy |  +1.94% |
| Basic Materials | +0.79% |
| Industrials | +1.04% |
| Cyclical Goods & Services | +0.45% |
| Non-Cyclical Goods & Services | +0.97% |
| Financials | +1.39% |
| Healthcare | +1.04% |
| Technology | +0.82% |
| Telecoms | +0.88% |
| Utilities | +1.30% |
| DOW | 12,627.01 | +92.34 |
+0.74% |
| S&P; 500 | 1,331.85 | +11.86 |
+0.90% |
| NASDAQ | 2,875.32 | +21.26 |
+0.74% |
| TR US Index | 120.37 | +1.09 |
+0.91% |
Upcoming Events
No related earnings announcements are currently scheduled within the next 7 days.
Analyst Research
| Report Title | Price |
|---|---|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$125.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
